In the News Stocks: Horizon Pharma plc (NASDAQ:HZNP), Chipotle Mexican Grill (NYSE:CMG), FleetCor Technologies (NYSE:FLT), Hemispherx Biopharma (NYSEMKT:HEB)

Regency Centers Corporation (NYSE:REG) shares moved down -3.38% in last trading session and ended the day at $74.51. REG Gross Margin is 74.60% and its has a return on assets of 3.10%. Regency Centers Corporation (NYSE:REG) quarterly performance is 10.50%.

Regency Centers Corporation (NYSE:REG) announced the pricing of an underwritten public offering of 3,100,000 shares of its common stock subject to the forward sale agreement described below, which will result in approximately $233 million of gross proceeds (assuming such forward sale agreement is physically settled based on the offer price to the public of $75.25, as described more fully below), before any underwriting discount and offering expenses.

Horizon Pharma plc (NASDAQ:HZNP) ended the last trading day at $14.02. Company weekly volatility is calculated as 9.08% and price to cash ratio as 2.61. Horizon Pharma plc (NASDAQ:HZNP) showed a weekly performance of -24.75%.

Lundin Law PC announces a class action lawsuit has been filed against Horizon Pharma plc (NASDAQ:HZNP) concerning possible violations of federal securities laws between March 13, 2014 and February 26, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the May 9, 2016, lead plaintiff motion deadline. According to the complaint, the Company failed to disclose that: (1) Horizon’s Prescriptions Made Easy (“PME”) program was designed to inflate the value of minor differentiation standard retail drugs; (2) sales revenues from drugs sold through Horizon’s PME program were not sustainable at these artificially inflated prices; and (3) Horizon’s use of its PME program left Horizon subject to additional regulatory risks.

In an effort to accelerate a recovery from E. coli outbreaks that pushed share prices to low points in recent months, Chipotle Mexican Grill Inc. has given away millions of burritos and says it will offer millions more. Chipotle Mexican Grill, Inc. (NYSE:CMG) received 5.3 million requests for free burritos over about five hours when every restaurant was closed on February 8, a “rain check” to customers who couldn’t purchase food, Chief Creative and Development Officer Mark Crumpacker told attendees at the Bank of America Merrill Lynch Consumer and Retail Tech Conference.
On 18 March, Chipotle Mexican Grill, Inc. (NYSE:CMG) shares moved down -3.44% and was closed at $455.37. CMG EPS growth in last 5 year was 21.80%. Chipotle Mexican Grill, Inc. (NYSE:CMG) year to date (YTD) performance is -5.10%.

On March 15, FleetCor Technologies, Inc. (NYSE:FLT) agreed on Tuesday to buy Brazil’s largest electronic toll payments firm for 4.086 billion reais ($1.1 billion), underscoring the growing allure of Latin America’s biggest fleet management market in spite of a steep recession. In a statement, Norcross, Georgia-based FleetCor said it acquired Serviços e Tecnologia de Pagamentos SA from a group of partners including rival toll road operators CCR SA and Arteris SA, energy and logistics conglomerate Raizen Combustiveis SA and others.
FleetCor Technologies, Inc. (NYSE:FLT) shares moved up 3.20% in last trading session and ended the day at $147.36. FLT Gross Margin is 93.60% and its has a return on assets of 4.40%. FleetCor Technologies, Inc. (NYSE:FLT) quarterly performance is 2.16%.

On March 10, Hemispherx Biopharma, Inc. (NYSEMKT:HEB) announced that the strong commitment by the National Institutes of Health (NIH) to advance research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) signals a major research effort by NIH in the diagnosis and treatment of this complex and poorly understood life-robbing disease.  Lead by NIH Director Francis S. Collins, M.D., Ph.D., the NIH held an open call with the ME/CFS patient community March 8 to detail some of those efforts.
Hemispherx Biopharma, Inc. (NYSEMKT:HEB) caters to the Healthcare space. Its weekly performance is -18.69%. On the last day of trading company shares ended up at $0.13. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) distance from 50-day simple moving average (SMA50) is 7.38%.